Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 1,621-1,632 of 6,115
Device study icon
Enrolling By InvitationNCT05967390

Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)

This summary needs review. Please check the official study record and contact the research team for details.

In Hong Kong
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 60 Years to 95 Years
Countries
China
Sponsor
Chinese University of Hong Kong
Condition
Depression
Drug study icon
CompletedNCT06423781

Safety study of BHV-7000 in depression

This study is completed in the United States. It is testing BHV-7000 for depression.

Multiple locations, including Chandler
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Biohaven Therapeutics Ltd.
Condition
Depression
Other study type icon
Enrolling By InvitationNCT07149428

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

This study is enrolling by invitation in the United States. It focuses on Depression.

In Bethesda
Why is this study shown?

This study is directly about Depression.

DepressionObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 99 Years
Countries
United States
Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Condition
Depression
Drug study icon
CompletedNCT03866252

LSD Therapy for Persons Suffering From Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Basel
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 25 Years
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Condition
Depression
Biological study icon
Active Not RecruitingNCT05174273

Neurocognitive Effects of FMT in MDD people with and Without IBS

This summary needs review. Please check the official study record and contact the research team for details.

In Calgary
Why is this study shown?

This study is directly about Depression.

DepressionBiologicalFrom 18 Years to 60 Years
Countries
Canada
Sponsor
Valerie Taylor
Condition
Depression
Behavioral study icon
CompletedNCT03096886

Novel Neural Circuit Biomarkers of Major Depression Response to CCBT

This summary needs review. Please check the official study record and contact the research team for details.

In Philadelphia
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Other study type icon
CompletedNCT05065580

OMT as an Adjunctive Treatment in MDD

This summary needs review. Please check the official study record and contact the research team for details.

In Saint Joseph
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Corewell Health South
Condition
Depression
Drug study icon
CompletedNCT06391593

PD, PK, and Safety of ALTO-203 in people with MDD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Tucson
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 25 Years to 64 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Drug study icon
CompletedNCT05712187

Phase 2b Study of ALTO-100 in MDD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Drug study icon
SuspendedNCT06705478

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

This study is suspended in the United States, in Botswana, in Brazil, .... It focuses on depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States, Botswana, Brazil, ...
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.